The 41st David A. Karnofsky Memorial Award Lecture: Academic Research Worldwide—Quo Vadis?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The 41st David A. Karnofsky Memorial Award Lecture: Academic Research Worldwide—Quo Vadis?
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 32, Issue 4, Pages 347-354
Publisher
American Society of Clinical Oncology (ASCO)
Online
2013-12-24
DOI
10.1200/jco.2013.53.2549
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement†
- (2013) H. A. Azim et al. ANNALS OF ONCOLOGY
- I-SPY 2 may change how clinical trials are conducted
- (2013) Carrie Printz CANCER
- Why Your Preferred Targeted Drugs May Become Unaffordable
- (2013) M. J. Piccart CANCER RESEARCH
- Metcalfe's law and the biology information commons
- (2013) Stephen H Friend et al. NATURE BIOTECHNOLOGY
- Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience
- (2013) O. Metzger-Filho et al. ONCOLOGIST
- Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy
- (2012) Amye J. Tevaarwerk et al. CANCER
- Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
- (2012) François-Clément Bidard et al. CANCER AND METASTASIS REVIEWS
- Mutational Processes Molding the Genomes of 21 Breast Cancers
- (2012) Serena Nik-Zainal et al. CELL
- Academia–Industry Partnerships: Are we ready for new models of partnership?
- (2012) Denis Lacombe et al. EUROPEAN JOURNAL OF CANCER
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
- (2012) José Baselga et al. LANCET
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Pathological Complete Response and Accelerated Drug Approval in Early Breast Cancer
- (2012) Tatiana M. Prowell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Large Hadron Collider project: organizational and financial matters (of physics at the terascale)
- (2012) J. Engelen PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES
- Impact assessment of the European Clinical Trials Directive: a longitudinal, prospective, observational study analyzing patterns and trends in clinical drug trial applications submitted since 2001 to regulatory agencies in six EU countries
- (2012) Markus Hartmann Trials
- Beyond trastuzumab: New treatment options for HER2-positive breast cancer
- (2011) Kamal S. Saini et al. BREAST
- Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2-Positive Cancer
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase
- (2011) Emiel Rutgers et al. EUROPEAN JOURNAL OF CANCER
- A Historical Perspective on Clinical Trials Innovation and Leadership
- (2011) David L. DeMets JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
- (2011) Meredith M Regan et al. LANCET ONCOLOGY
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Postmastectomy Radiotherapy: Will the Selective Use of Postmastectomy Radiotherapy Study End the Debate?
- (2009) Nicola S. Russell et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started